Thu. 29 Feb 2024, 6:52am ET
Benzinga
Earnings, News
ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $1.00 per share which beat the analyst consensus estimate of $0.85 by 17.65 percent. This is a 31.58 percent increase over earnings of $0.76 per share from the same period last year. The company reported quarterly sales of $131.65 million which beat the analyst consensus estimate of $122.21 million by 7.73 percent. This is a 39.71 percent increase over sales of $94.23 million the same period last year.